Arcutis Biotherapeutics, Inc.

ARQT stock score: 61/100

$31.87 · -2.89% · Scored Oct 21, 2026

Technical
72
Fundamental
51
News
53

The reading

Arcutis Biotherapeutics (ARQT) scores 61 out of 100, which reads neutral, higher than 89% of Healthcare stocks and 80% of the 4,166 US stocks we score.

The composite is technicals and fundamentals weighted equally: technicals read 72, fundamentals 51.

Among the fundamentals, Price Target at 100 and Fund Ownership at 100 score highest, while EV/EBITDA at 0 weighs the most against it.

On the daily chart, trend-following indicators average 78 and contrarian oscillators 26 — a split worth reading before trusting the technical total.

News sentiment is neutral at 53; it is shown, not counted in the composite.

Since Jul 25, 2026 the composite has ranged from 50 to 63, and it ends the period where it started.

What’s driving the score

The strongest and weakest of the scorers that count toward ARQT’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

51

Pulling it up

  • Price Target100

    Price target score compares the current stock price to analyst consensus targets.

  • Fund Ownership100

    Fund ownership tracks institutional investor holdings and changes.

  • Revenue Growth (5-Year)100

    5-year revenue growth analyzes long-term sales trajectory and consistency.

Holding it back

  • EV/EBITDA0

    EV/EBITDA compares the whole company's value, debt included, with its operating earnings before depreciation.

  • Price to Book Ratio0

    Price-to-Book ratio compares market value to book value.

  • Trailing P/E0

    Trailing P/E ratio uses the last 12 months of actual earnings.

40 weighted scorers; 1 had no data today and are left out rather than counted as zero.

Technical · daily

71

Pulling it up

  • Percentage Price Oscillator (PPO)100

    Percentage Price Oscillator shows the difference between two moving averages as a percentage.

  • Rate of Change (ROC)100

    Rate of Change measures the percentage change in price over a specified period.

  • Parabolic SAR (PSAR)100

    Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.

Holding it back

  • Bollinger Bands (50)0

    Bollinger Bands (50-period) measure where price sits between bands two standard deviations around its 50-period average.

  • Bollinger Bands (20)0

    Bollinger Bands (20-period) plot standard deviations above and below a moving average.

  • RSI (14)2

    Relative Strength Index (14-period) measures momentum by comparing recent gains to losses.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
53

Technical score by timeframe

ChartScoreWeight
Hourly521
Daily713
Weekly732
Monthly752
Quarterly782

Composite score, last 90 days

05010061Jul 25, 2026Oct 21, 2026Jul 25, 2026: 61Jul 26, 2026: 61Jul 27, 2026: 63Jul 28, 2026: 62Jul 29, 2026: 62Jul 30, 2026: 62Jul 31, 2026: 60Aug 2, 2026: 57Aug 3, 2026: 52Aug 5, 2026: 54Aug 6, 2026: 53Aug 7, 2026: 55Aug 8, 2026: 55Aug 9, 2026: 55Aug 10, 2026: 55Aug 11, 2026: 58Aug 12, 2026: 58Aug 13, 2026: 56Aug 14, 2026: 57Aug 15, 2026: 56Aug 16, 2026: 56Aug 17, 2026: 56Aug 18, 2026: 58Aug 19, 2026: 59Aug 20, 2026: 57Aug 22, 2026: 55Aug 23, 2026: 55Aug 24, 2026: 54Aug 25, 2026: 55Aug 26, 2026: 56Aug 27, 2026: 55Aug 28, 2026: 52Aug 29, 2026: 53Aug 30, 2026: 53Aug 31, 2026: 53Sep 1, 2026: 54Sep 2, 2026: 56Sep 3, 2026: 50Sep 4, 2026: 54Sep 5, 2026: 53Sep 6, 2026: 53Sep 7, 2026: 53Sep 8, 2026: 57Sep 9, 2026: 53Sep 10, 2026: 50Sep 11, 2026: 53Sep 12, 2026: 53Sep 13, 2026: 53Sep 14, 2026: 54Sep 15, 2026: 52Sep 16, 2026: 58Sep 17, 2026: 59Sep 18, 2026: 58Sep 19, 2026: 58Sep 20, 2026: 58Sep 21, 2026: 59Sep 22, 2026: 61Sep 23, 2026: 60Sep 24, 2026: 60Sep 25, 2026: 60Sep 26, 2026: 60Sep 27, 2026: 60Sep 28, 2026: 61Sep 29, 2026: 60Sep 30, 2026: 58Oct 1, 2026: 55Oct 2, 2026: 54Oct 3, 2026: 54Oct 4, 2026: 54Oct 5, 2026: 54Oct 6, 2026: 51Oct 7, 2026: 51Oct 8, 2026: 52Oct 9, 2026: 58Oct 10, 2026: 59Oct 11, 2026: 59Oct 12, 2026: 59Oct 13, 2026: 59Oct 14, 2026: 58Oct 15, 2026: 60Oct 16, 2026: 61Oct 17, 2026: 61Oct 18, 2026: 61Oct 19, 2026: 61Oct 20, 2026: 62Oct 21, 2026: 61
Show the daily numbers
DateComposite
Oct 21, 202661
Oct 20, 202662
Oct 19, 202661
Oct 18, 202661
Oct 17, 202661
Oct 16, 202661
Oct 15, 202660
Oct 14, 202658
Oct 13, 202659
Oct 12, 202659
Oct 11, 202659
Oct 10, 202659
Oct 9, 202658
Oct 8, 202652
Oct 7, 202651
Oct 6, 202651
Oct 5, 202654
Oct 4, 202654
Oct 3, 202654
Oct 2, 202654
Oct 1, 202655
Sep 30, 202658
Sep 29, 202660
Sep 28, 202661
Sep 27, 202660
Sep 26, 202660
Sep 25, 202660
Sep 24, 202660
Sep 23, 202660
Sep 22, 202661
Sep 21, 202659
Sep 20, 202658
Sep 19, 202658
Sep 18, 202658
Sep 17, 202659
Sep 16, 202658
Sep 15, 202652
Sep 14, 202654
Sep 13, 202653
Sep 12, 202653
Sep 11, 202653
Sep 10, 202650
Sep 9, 202653
Sep 8, 202657
Sep 7, 202653
Sep 6, 202653
Sep 5, 202653
Sep 4, 202654
Sep 3, 202650
Sep 2, 202656
Sep 1, 202654
Aug 31, 202653
Aug 30, 202653
Aug 29, 202653
Aug 28, 202652
Aug 27, 202655
Aug 26, 202656
Aug 25, 202655
Aug 24, 202654
Aug 23, 202655
Aug 22, 202655
Aug 20, 202657
Aug 19, 202659
Aug 18, 202658
Aug 17, 202656
Aug 16, 202656
Aug 15, 202656
Aug 14, 202657
Aug 13, 202656
Aug 12, 202658
Aug 11, 202658
Aug 10, 202655
Aug 9, 202655
Aug 8, 202655
Aug 7, 202655
Aug 6, 202653
Aug 5, 202654
Aug 3, 202652
Aug 2, 202657
Jul 31, 202660
Jul 30, 202662
Jul 29, 202662
Jul 28, 202662
Jul 27, 202663
Jul 26, 202661
Jul 25, 202661

Key facts

Market cap
$4.0B
Sector
Healthcare
Industry
Biotechnology
Beta
1.58
Risk grade (1–10)
6
Next earnings
Nov 4, 2026

Biotechnology peers

CompanyMarket capScore
DNTH Dianthus Therapeutics$4.4B45
EWTX Edgewise Therapeutics$4.3B46
TNGX Tango Therapeutics$4.3B53
RLAY Relay Therapeutics$4.0B49
ABCL AbCellera Biologics$3.8B51
TLX Telix Pharmaceuticals$3.8B51

Questions

What is ARQT's stock score today?

ARQT scores 61/100 (Neutral) as of Oct 21, 2026: technical 72, fundamental 51, and news sentiment 53, which is shown but not counted. Scores are recomputed every night.

Is ARQT a buy?

The score is not a buy or sell recommendation. A 61 says the technical and fundamental signals we measure lean neutral today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the ARQT score calculated?

102 weighted scorers feed it today: 40 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.